Sign in →

Test ID AD2 PrecivityAD2, Plasma


Ordering Guidance


This blood test is intended for use in adults aged 40 years and older who present with signs or symptoms of cognitive impairment undergoing evaluation for Alzheimer disease or other forms of cognitive decline. The test is not intended as a screening or stand-alone diagnostic test.



Shipping Instructions


1. Specimens must be shipped frozen on dry ice.

2. Place labeled aliquot tubes inside a larger tube or vial for transport.



Specimen Required


Supplies: Screw cap micro tube, 2 mL, PCR Performance Tested, Low protein-binding (T983)

Collection Container/Tube: 10 mL Purple top (K2-EDTA)

Submission Container/Tube: Two 2-mL screw cap micro tubes

Specimen Volume: 3 mL Plasma in 2 tubes, each containing 1.5 mL plasma

Collection Instructions:

1. Label two 2-mL screw-cap micro tubes.

2. Within 2 hours of collection, centrifuge and aliquot 1.5 mL of plasma into each labeled micro tube.

3. Freeze plasma (no longer than 2 hours after collection) at or below -20° C.

Note: If plasma sample is not being shipped on the day of collection/processing, the sample needs to be stored at -80° C.


Useful For

Assisting in the evaluation of adults aged 40 years and older, who present with signs or symptoms of cognitive impairment undergoing evaluation for Alzheimer disease or other forms of cognitive decline

 

This test is not intended for use as a screening or stand-alone diagnostic test. The safety and effectiveness of the PrecivityAD2 test have not been established for predicting development of dementia or other neurologic conditions, or for monitoring responses to therapies.

Method Name

Immunoprecipitation/Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

Reporting Name

PrecivityAD2

Specimen Type

Plasma

Specimen Minimum Volume

See Specimen Required

Specimen Stability Information

Specimen Type Temperature Time
Plasma Frozen

Reference Values

Amyloid Probability Score 2 (APS2) (range of 0-100):

 

Positive

>66.5 is consistent with brain amyloid pathology

 

Likely Positive

>27.5 to < 66.5 is likely consistent with brain amyloid pathology

 

Negative

<27.5 is not consistent with brain amyloid pathology

APS2 results are reported as whole numbers from 0-100. The reporting ranges shown above are based on the APS2 cut points specified in the FDA-cleared PrecivityAD2 labeling.

Day(s) Performed

Monday through Friday

Report Available

13 days post sample receipt from MCL

Performing Laboratory

C2N Diagnostics LLC

Test Classification

This test has been cleared by the U.S. Food and Drug Administration (FDA) under 510(k) K253240 and is performed according to the FDA-cleared labeling at C2N Diagnostics Laboratory. For prescription use only.

CPT Code Information

0503U

LOINC Code Information

Test ID Test Order Name Order LOINC Value
AD2 PrecivityAD2 Not Provided

 

Result ID Test Result Name Result LOINC Value
PD2A Amyloid Probability Score Not Provided
PD2B APS2 Result Not Provided
PD2C Interpretation Not Provided
PD2D Indication for Use of the Test Not Provided
PD2E Test Description and Clinical Performance Not Provided
PD2F Limitations Not Provided
PD2G Report Comment Not Provided
PD2H Performing Site Not Provided